Speciality Pharma

With breakthrough data on the horizon, a global biopharmaceutical company recognized the need to sharpen its U.S. Medical Affairs teams’ ability to engage peers with clarity, confidence, and influence. Focused on oncology and neuroscience, the company sought to ensure its Medical Science Liaisons (MSLs) were ready to deliver high-stakes scientific narratives in a way that truly resonated with stakeholders.

Tailored U.S. Rollout of a Proven Capability Framework

We adapted a European “Influence with Impact” program to the U.S. context, co-creating training modules that reflected local market challenges, customer expectations, and internal capability needs.

Modular, Multi-Format Learning Experience

The engagement included:

• Virtual briefings, kickoff sessions, and alignment meetings with internal change champions.

• Co-development of facilitation content, exercises, and “data challenge” scenarios.

• Delivery of in-person and virtual workshops for teams across Solid Tumors, Hematology/Oncology, and Epilepsy & Movement Disorders.

Coaching and Measurement Integration

We supported survey design and feedback tools to assess pre- and post-training confidence and capability, and we joined follow-up meetings to help interpret findings and inform future rollout phases.

By bridging content adaptation, co-creation, delivery, and capability measurement across diverse disease areas, this engagement exemplified the value of scalable communication frameworks tailored to scientific exchange—and embedded within a broader culture shift toward performance excellence.

• Equipped field medical teams with practical, repeatable tools to communicate complex data in high-impact, peer-to-peer settings.

• Fostered alignment and skill building across cross-functional groups by bringing consistent frameworks to three distinct therapeutic areas.

• Captured measurable gains in capability through structured pre-/post-training evaluations.